Q4 2023 Getinge AB Earnings Call Transcript
()-&
Thank you very much, and welcome, everyone, to today's conference. I have Lars Sandström with me here today, and he will do the deep dive into the financials and also help with the Q&A a bit later. But we can move directly into page number 2 to look at the key takeaways for the fourth quarter of last year.
In terms of sales, getting us to net sales increased by 16.5% in the fourth quarter, and this is following growth in all business areas and regions. Organic growth accounted for 10.1% of these acquisitions for 5% and currency for one point, our order intake increased by 4.1% in the quarter, driven by acquisitions and currency. Organically, it decreased by 2.4%, which is mainly due to the challenging comparative figures from 2022 in connection with China lifting its COVID-19 restrictions back then.
Despite the increased sales, the adjusted EBITA margin was lower than last year, mainly due to the quality cost for the improvement work in Acute Care Therapies that we've had since the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |